1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 2: Demographic data of the study group
EKOS MCA Control MCA P EKOS BA Control BA P
No. of subjects 7 44 – 7 12 –
Age (mean) (yr) 69.1 ± 11.4 68.7 ± 11.2 <.05 61.0 ± 9.4 68.9 ± 12.9 <.05
Males (No.) (%) 5 (71.4%) 22 (50.0%) <.05 5 (71.4%) 9 (75.0%) <.05
Arterial hypertension (No.) (%) 7 (100%) 33 (75.0%) <.05 4 (57.1%) 9 (75.0%) <.05
Diabetes mellitus (No.) (%) 2 (28.6%) 8 (18.2%) <.05 1 (14.3%) 3 (25.0%) <.05
Hyperlipidemia (No.) (%) 2 (28.6%) 9 (20.5%) <.05 2 (28.6%) 5 (41.7%) <.05
Atrial fibrillation (No.) (%) 2 (28.6%) 19 (43.2%) <.05 2 (28.6%) 4 (33.3%) <.05
Smoking (No.) (%) 2 (28.6%) 8 (18.2%) <.05 1 (14.3%) 2 (25.0%) <.05
Heavy alcohol consumption (No.) (%) 0 (0%) 1 (2.3%) <.05 0 (0%) 0 (0%) <.05
ICA/VA stenosis >50% (No.) (%) 1/0 (14.3/0%) 7/0 (15.9/0%) <.05 0/3 (0/42.3%) 0/4 (0/33.3%) <.05
Left hemisphere (No.) (%) 3 (42.9%) 25 (56.8%) <.05 – – –
Use of acetylsalicylic acid (No.) (%) 2 (28.6%) 15 (34.1%) <.05 2 (28.6%) 4 (33.3%) <.05
Stroke in medical history (No.) (%) 1 (14.3%) 7 (15.9%) <.05 1 (14.3%) 3 (25.0%) <.05
Myocardial infarction in history (No.) (%) 1 (14.3%) 8 (18.2%) <.05 1 (14.3%) 2 (16.7%) <.05
IV thrombolysis (No.) (%) 3 (42.9%) 26 (59.1%) <.05 2 (28.6%) 6 (50.0%) <.05
IAT (No.) (%) 6 (85.7%) 0 (0%) – 7 (100%) 0 (0%) –
cPTAS (No.) (%) 3 (42.9%) 0 (0%) – 5 (71.4%) 0 (0%) –
Note:—VA indicates vertebral artery; EKOS, EkoSonic Endovascular System.